Rethinking immunization programs through the life course approach.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 13 12 2023
accepted: 19 02 2024
medline: 18 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: epublish

Résumé

The world continues to undergo a profound demographic shift toward increasing longevity -but quality of life is not improving correspondingly. At the same time, countries are taking stock of the negative impacts of the COVID-19 pandemic on national immunization programs. The pandemic exacerbated the declines in vaccination coverage for multiple vaccine-preventable diseases (VPD). To ensure that all persons receive all the vaccines for which they are eligible, it is time to consider how applying a life course approach (LCA) to immunization programs can help reinvigorate and redesign actions for greater vaccine uptake. In this mini review, we present the key concepts and principles of the LCA as applied to national immunization programs. Also, we offer recommendations on how health systems can achieve regional and national goals to ensure all people receive the recommended vaccine doses at every stage of life, thus ensuring the greatest benefits for individuals and societies.

Identifiants

pubmed: 38487192
doi: 10.3389/fpubh.2024.1355384
pmc: PMC10937433
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1355384

Informations de copyright

Copyright © 2024 Balsells, Ghiselli, Hommes, Nascimento Lins de Oliveira, Rosado-Valenzuela and Vega.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Expert Rev Vaccines. 2018 Oct;17(10):851-864
pubmed: 30350731
Rev Panam Salud Publica. 2017 Dec 12;41:e139
pubmed: 31384266
N Engl J Med. 2020 Oct 1;383(14):1340-1348
pubmed: 32997908
Lancet. 2022 Jan 8;399(10320):152-160
pubmed: 34741818
Public Health. 2022 Aug;209:82-89
pubmed: 35870290
F1000Res. 2022 Feb 16;11:198
pubmed: 35811799
Ageing Res Rev. 2021 Nov;71:101422
pubmed: 34391943
Rev Panam Salud Publica. 2022 Nov 15;46:e182
pubmed: 36406294
Rev Panam Salud Publica. 2022 Jun 21;46:e65
pubmed: 35747470
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398

Auteurs

Evelyn Balsells (E)

Pan American Health Organization, Washington, DC, United States.

Margherita Ghiselli (M)

Pan American Health Organization, Washington, DC, United States.

Carolina Hommes (C)

Pan American Health Organization, Washington, DC, United States.

Beatriz Nascimento Lins de Oliveira (B)

Pan American Health Organization, Washington, DC, United States.

Ana Lucía Rosado-Valenzuela (AL)

Pan American Health Organization, Washington, DC, United States.

Enrique Vega (E)

Pan American Health Organization, Washington, DC, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH